Gene and immunotherapeutic approaches to treat human malignant tumors are r
eviewed. Special attention is given to the different strategies of cancer g
ene therapy and to recent aspects of cytokine-supported tumor immunotherapy
or tumor-specific vaccination. The limitations of these therapy approaches
are critically discussed especially with respect to immune escape mechanis
ms.